Blockchain technology for secure and efficient nephrology data management

Clicks: 1
ID: 317148
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #103 of 127 articles by views in clinical kidney journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 127 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Rapid advancements in digital healthcare technologies have created new opportunities in nephrology, but they have also increased the fragmentation of datasets, complexity of data sharing, data privacy and security risks, and a lack of data verifiability and reliability (provenance). While several technological solutions have been developed to address these concerns individually, blockchain has been suggested as a unified solution for secure and efficient data management through several features. These include immutability, interoperability, and programmability, which provide a powerful framework that extends the utility of blockchain beyond data governance in nephrology. Blockchain also has potential applications in pharmaceutical and biobanking quality assurance and in the reliability of medical devices through auditable maintenance logs, making it a promising candidate to address several challenges in patient care and nephrology research. Despite this promise, practical challenges arise between the features of blockchain, such as immutability, and legislation, including the General Data Protection Regulation (GDPR). Furthermore, the value of real-world adoption in nephrology remains uncertain due to scalability, computational overheads, and implementation costs that may outweigh its advantages in many settings.
Reference Key
openalex_W7164519763 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors David R Evans, Ömer Tarik Özyilmaz, Huifang Xue, Michele Provenzano, Ning Qu, Stephan J L Bakker, Martin H. de Borst, Uwe J F Tietge, Tamás Szili‐Török
Journal clinical kidney journal
Year 2026
DOI
10.1093/ckj/sfag201
URL
https://doi.org/10.1093/ckj/sfag201
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.